Table 2.
Univariate |
Multivariate |
|||||
---|---|---|---|---|---|---|
Variable | HR | CI (95%) | P value | HR | CI (95%) | P value |
Gender | 1.16 | 0.68–1.97 | 0.58 | |||
Age | 1.38 | 0.83–2.29 | 0.21 | |||
Tumor location | 0.99 | 0.72–1.35 | 0.96 | |||
Pathological type | 0.95 | 0.69–1.31 | 0.72 | |||
Tumor size | 2.84 | 1.34–5.98 | 0.006 | 1.32 | 0.60–2.93 | 0.48 |
Depth of invasion | 2.48 | 1.47–4.20 | 0.001 | 1.70 | 0.97–2.97 | 0.06 |
Lymph node metastasis | 6.18 | 2.46–15.51 | <0.001 | 3.19 | 1.12–9.08 | 0.029 |
Distant metastasis | 8.51 | 4.95–14.62 | <0.001 | 3.45 | 1.18–10.07 | 0.024 |
AJCC stage | 3.99 | 2.75–5.79 | <0.001 | 2.14 | 1.07–4.28 | 0.031 |
TPX2 | 3.60 | 2.08–6.22 | <0.001 | 2.17 | 1.23–3.81 | 0.007 |
HR, hazard ratio; CI, confidence interval; AJCC, American Joint Committee on Cancer; TPX2, Targeting protein for Xklp2.